Chemomab Therapeutics Ltd. American Depositary Share
Last updated September 27, 2026
Organization details
- Legal name
- Chemomab Therapeutics Ltd. American Depositary Share
- Ownership
- Public
- Status
- Active
- Headquarters country
- Israel
- Ticker symbol
- CMMB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001534248
Board of directors
-
Alan Charles Moses · DirectorSince 2023
-
Claude Nicaise · DirectorSince 2026
-
George Adi Mor · Director · Chief Scientific OfficerSince 2023
-
Jill M. Quigley · DirectorSince 2026
-
Neil Harris Cohen · DirectorSince 2023
-
Nissim Darvish · DirectorSince 2023
Board connections
2 of this board's directors also sit on 4 other boards.
- via Claude Nicaise
- via Claude Nicaise
- via Claude Nicaise
- via Alan Charles Moses
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 3, 2023 | OrbiMed Israel BioFund GP Limited Partnership 10% owner | Open-market sale | −266,376 | $3.34 | $889,696 |
| Jan 3, 2023 | George Adi Mor Director, Officer (Chief Scientific Officer) | Open-market sale | −7,700 | $5.03 | $38,731 |
| Jan 3, 2023 | OrbiMed Israel BioFund GP Limited Partnership 10% owner | Open-market sale | −70,524 | $4.51 | $318,063 |
| Jan 3, 2023 | George Adi Mor Director, Officer (Chief Scientific Officer) | Open-market sale | −6,100 | $5.03 | $30,683 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.